Lysine — Veterinary Vademecum Drug Reference

Dosage & Administration Guidelines

Species	Route	Dose	Frequency	Duration & Clinical Notes
Cat	PO	250-500 mg per cat	q12h (every 12 hours)	Duration: Variable; often used long-term for chronic FHV-1 management Notes: May be given as a powder mixed with food or as a paste. Some studies suggest higher doses (up to 1000 mg/day) may be more effective, but efficacy is debated.
Dog	PO	Not established; typically 10-20 mg/kg	q24h	Duration: As needed for nutritional support Notes: Not a standard therapeutic agent in dogs; use only under veterinary guidance.
Horse	PO	Not established; typically 10-20 g/day	q24h	Duration: As needed for nutritional support Notes: Used as a feed supplement; not a standard therapeutic agent.

Clinical Indications & Species Uses

General Indications

Nutritional supplement for growth and tissue repair
Supportive therapy in patients with protein malnutrition

Cat (Feline)

Adjunctive therapy for feline herpesvirus type 1 (FHV-1) infections
Reduction of clinical signs associated with FHV-1 (e.g., conjunctivitis, sneezing, ocular discharge)
Prevention of FHV-1 recurrences in chronically infected cats

Pharmacology & Mechanism of Action

Drug Class: Amino Acid Supplement | Pharmacological Group: Essential Amino Acid / Nutritional Supplement

Mechanism of Action: Lysine is an essential amino acid that must be provided in the diet. In veterinary medicine, particularly in cats, supplemental lysine is used to inhibit the replication of feline herpesvirus type 1 (FHV-1). The proposed mechanism involves competitive inhibition of arginine, an amino acid required for viral replication. Lysine is thought to reduce the availability of arginine for viral protein synthesis, thereby suppressing viral growth and reducing the severity and frequency of herpesvirus outbreaks. Additionally, lysine may have direct antiviral effects by interfering with viral envelope formation.

Pharmacodynamics: Lysine supplementation increases plasma lysine concentrations, which may competitively inhibit arginine transport and utilization. In cats, high dietary lysine has been shown to reduce FHV-1 shedding and clinical signs in some studies, although results are variable. It does not eliminate the virus but may help manage clinical signs. Lysine also plays a role in collagen formation, calcium absorption, and the production of carnitine, which is important for fatty acid metabolism.

⚡ Pharmacokinetics Summary

Absorption: Lysine is absorbed from the small intestine via carrier-mediated transport. Absorption is efficient and occurs rapidly after oral administration. Bioavailability is high, though it may be reduced when given with large meals due to competition with other amino acids.

Distribution: Lysine is distributed widely throughout the body, with highest concentrations in muscle tissue. It crosses the blood-brain barrier and is taken up by tissues for protein synthesis. In cats, plasma lysine concentrations peak within 1-2 hours after oral administration.

Metabolism: Lysine is metabolized primarily in the liver via the saccharopine pathway. It is not stored in the body to any significant extent and must be obtained from the diet.

Excretion: Lysine is excreted mainly in the urine as urea and other metabolites. A small amount is excreted in feces. In cats, renal excretion increases with high doses.

Half-Life: The half-life of lysine in cats is approximately 2-3 hours. In dogs, it is similar, around 2-4 hours.

Bioavailability: Oral bioavailability is high, estimated at 70-90% in cats and dogs, depending on the formulation and presence of food.

Protein Binding: Lysine is not significantly bound to plasma proteins.

Available Formulations & Strengths

Oral Powder Various (e.g., 500 mg per scoop, 1000 mg per scoop) (PO)

Oral Paste Various (e.g., 500 mg per mL) (PO)

Oral Tablet/Capsule 250 mg, 500 mg, 1000 mg (PO)

Contraindications & Clinical Warnings

Contraindications:

Known hypersensitivity to lysine or any component of the formulation
Patients with hyperlysinemia (rare genetic disorder)
Severe renal impairment (use with caution; may require dose adjustment)

Warnings & Clinical Precautions:

Efficacy in treating FHV-1 is controversial; some studies show benefit, others do not. Use as an adjunct to standard antiviral therapy.
Do not use as a substitute for antiviral drugs in severe cases.
Use with caution in pregnant or lactating animals; safety not fully established.
High doses may cause gastrointestinal upset.
In cats, excessive lysine may lead to arginine deficiency, which can be harmful.
Monitor renal function in animals with pre-existing kidney disease.

Adverse Effects & Reactions

Common:

Gastrointestinal upset (vomiting, diarrhea)
Decreased appetite

Serious / Severe:

Arginine deficiency (with excessive doses)
Hyperlysinemia (rare)

Rare:

Allergic reactions (rash, urticaria)

Key Drug Interactions

Interacting Drug / Class	Clinical Effect & Mechanism	Severity
Arginine	Lysine and arginine compete for absorption and transport; high lysine may reduce arginine availability, potentially worsening conditions requiring arginine.	Moderate
Aminoglycoside antibiotics	Potential increased risk of nephrotoxicity due to competition for renal transport; monitor renal function.	Mild
Corticosteroids	May increase protein catabolism, potentially increasing lysine requirements.	Mild

Overdose & Toxicity Management

Signs of Toxicity:

Gastrointestinal upset (vomiting, diarrhea)
Neurological signs (tremors, ataxia) in severe cases
Arginine deficiency signs (hyperammonemia, lethargy)

Emergency Treatment Protocol: Treatment is symptomatic and supportive. Discontinue lysine supplementation. Provide supportive care including fluid therapy and antiemetics if needed. In cases of suspected arginine deficiency, administer arginine supplementation. Monitor electrolyte balance and renal function.

Food Animal Withdrawal Times

🥩 Meat: 0 days🥛 Milk: 0 days🥚 Eggs: 0 days

Lysine is a naturally occurring amino acid and is not subject to withdrawal times in food animals. However, if used in food animals, follow label directions and consult with a veterinarian.

Storage, Handling & Regulatory Information

Storage Temperature: Store at room temperature (20-25°C / 68-77°F)

Handling & Special Conditions: Keep container tightly closed. Protect from moisture. Store away from direct heat.

Dispensing Status: Over-The-Counter (OTC)

Approval Status: Not FDA-approved as a veterinary drug; considered a dietary supplement.

Extra-Label (Off-Label) Use: Lysine is a nutritional supplement and is generally not regulated as a prescription drug. In the US, it is available over-the-counter. Extra-label use in food animals is not common, but if used, it must comply with AMDUCA regulations.

Clinical Pearls & Practice Notes

💡 Clinical Insights: Lysine is primarily used in cats as an adjunctive therapy for feline herpesvirus type 1 (FHV-1) infections. While some studies have shown a reduction in viral shedding and clinical signs, others have not demonstrated significant benefit. It is generally considered safe, but its efficacy is debated. It is important to note that lysine should not replace antiviral medications such as famciclovir in severe cases. For cats with recurrent FHV-1, lysine may be used as a preventive measure, but owners should be informed of the limited evidence. In other species, lysine is used as a nutritional supplement to support growth and tissue repair. Always consult a veterinarian before starting supplementation, especially in animals with renal disease or those on other medications.

References & Literature

📚 Plumb's Veterinary Drug Handbook
📚 Papich Veterinary Pharmacology and Therapeutics
📚 Compendium of Veterinary Products (CVP)